Eli Lilly can not walk away from a contract - lets be rational here - patient or no patient Eli Lilly is still making good money with this product why would they change their approach.
Also on the patients - Acurx has multiple patients on axiron - I'm not 100% clear what hs been struck out but pretty sure it is not all of the portfolio... they will need to clarify this position on the call..
Eli Lilly can not walk away from a contract - lets be rational...
Add ACR (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
6.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $17.44M | |||
| Open | High | Low | Value | Volume |
| 0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 100000 | 6.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 6.5¢ | 73455 | 1 |
View Market Depth
| Last trade - 16.12pm 09/07/2024 (20 minute delay) ? |
| ACR (ASX) Chart |
Day chart unavailable